Trials / Enrolling By Invitation
Enrolling By InvitationNCT04279496
Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry
Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 35,000 (estimated)
- Sponsor
- Cleerly, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The overall objective of CONFIRM2 is to perform the largest cardiovascular phenotype outcomes study ever.
Detailed description
CONFIRM2 is a retrospective and prospective, open-label, international, multicenter observational registry designed to evaluate associations between CCTA imaging findings and clinical presentation (cross-sectional) and their ability to predict mortality and major adverse cardiac events (longitudinal) in patients with chronic CAD.
Conditions
Timeline
- Start date
- 2020-06-01
- Primary completion
- 2027-06-01
- Completion
- 2027-06-01
- First posted
- 2020-02-21
- Last updated
- 2024-11-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04279496. Inclusion in this directory is not an endorsement.